MAVS and systemic lupus erythematosus: Moreover, MAVS C79F lost its ability to trigger the activation of type I IFN signaling under SeV or IC poly(I:C) treatment conditions (Figure 1Q), suggesting that SLE patients with MAVS C79F are at increased risk of viral infection.